Etripamil
Etripamil (MSP-2017) is a short-acting, L-type calcium-channel antagonist. Etripamil inhibits calcium influx through slow calcium channels, thereby slowing AV node conduction and prolonging the AV node refractory period. Etripamil increases heart rate and decreases systolic blood pressure. Etripamil can be used in the study of paroxysmal supraventricular tachycardia (PSVT) [1][2][3][4].
Product Specifications
CAS Number
1593673-23-4
Product Name Alternative
MSP-2017; (-) -MSP-2017
UNSPSC
12352005
Target
Calcium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Neurological Disease; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/etripamil.html
Purity
98.10
Solubility
Ethanol : 120 mg/mL (ultrasonic)
Smiles
O=C(OC)C1=CC=CC(CCN(CCC[C@](C2=CC=C(OC)C(OC)=C2)(C#N)C(C)C)C)=C1
Molecular Formula
C27H36N2O4
Molecular Weight
452.59
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
L-type calcium channel
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![LANCL2 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI2A11]](https://cdn.genprice.uk/products/937/6868c385994c49e6dc3f93ef/imageurl/ta800180am.webp)
LANCL2 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI2A11]
DUT (Deoxyuridine 5'-triphosphate Nucleotidohydrolase, Mitochondrial, dUTPase, dUTP Pyrophosphatase) (MaxLight 750) discontinued
